← FDA Drug Approvals (Drugs@FDA)
CHLORDIAZEPOXIDE HYDROCHLORIDE AND CLIDINIUM BROMIDE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: TORRENT · Approved 2023-12-14
Drug application
- FDA Application #
ANDA217385- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- CHLORDIAZEPOXIDE HYDROCHLORIDE AND CLIDINIUM BROMIDE
- Generic name
- Chlordiazepoxide Hydrochloride
- Active ingredients
- CHLORDIAZEPOXIDE HYDROCHLORIDE; CLIDINIUM BROMIDE
- Dosage form
- CAPSULE
- Route
- ORAL
- Marketing status
- Discontinued
- Sponsor
- TORRENT
- First approval
- 2023-12-14
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown